Trading Signals: CGEN Stock Price Prediction and Forecast (Wed. Jun. 11, 2003 - Fri. May. 13, 2022)(Compugen Ltd.)
| CGEN latest price $2.0750 (-5.9%) ($2.0750 - $2.0750) on Fri. May. 6, 2022. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 4.15% (three month average) | RSI | 33 | Latest Price | $2.0750(-5.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CGEN declines -2.6% a day on average for past five trading days. | Weekly Trend | CGEN declines -4.7% a week on average for past two weeks. | Market Behavior | Growth stock sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support CGEN advance at 0% a week (0% probability) XLY(98%) IBUY(96%) ARKK(95%) IFRA(95%) XRT(95%) | Factors Impacting CGEN price | CGEN will decline at least -2.075% in a week (0% probabilities). BWX(29%) LQD(35%) UUP(-9%) SHY(2%) BNDX(14%) | | | | | Relative Volatility | | | | Market Trend Strength | -2.075% (StdDev 4.15%) | Hourly BBV | -1.3 () | Intraday Trend | 0% | | | |
|
1 - 5 Day Possible Target | $-13.15(-733.73%) | Resistance Level | $2.47 | 5 Day Moving Average | $2.27(-8.59%) | 10 Day Moving Average | $2.32(-10.56%) | 20 Day Moving Average | $2.47(-15.99%) | To recent high | -39.9% | To recent low | 0% | Market Cap | $172m | | | | Compugen Ltd. engages in the research, development, and commercialization of therapeutic and diagnostic biomarker product candidates including proteins and monoclonal antibodies. It focuses its research and development on immuno-oncology and autoimmune diseases. The company was founded by Eli Mintz, Simchon Faigler, and Amir Natan on February 10, 1993 and is headquartered in Holon, Israel. |